Dallas
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stazzone, Kathryn
NCT05665699: Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

Recruiting
2
80
US
D-0120, Allopurinol
InventisBio Co., Ltd
Gout
07/25
12/25

Download Options